Pacific Biosciences Of California Quick Ratio 2010-2023 | PACB
Historical quick ratio values for Pacific Biosciences Of California (PACB) over the last 10 years.
| Pacific Biosciences Of California Quick Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
| 2023-12-31 | $0.69B | $0.10B | 7.21 |
| 2023-09-30 | $0.81B | $0.18B | 4.43 |
| 2023-06-30 | $0.87B | $0.27B | 3.20 |
| 2023-03-31 | $0.92B | $0.27B | 3.46 |
| 2022-12-31 | $0.80B | $0.26B | 3.04 |
| 2022-09-30 | $0.87B | $0.08B | 10.66 |
| 2022-06-30 | $0.93B | $0.08B | 11.07 |
| 2022-03-31 | $1.00B | $0.06B | 16.38 |
| 2021-12-31 | $1.08B | $0.07B | 15.01 |
| 2021-09-30 | $1.11B | $0.06B | 19.99 |
| 2021-06-30 | $1.17B | $0.05B | 25.78 |
| 2021-03-31 | $1.18B | $0.03B | 34.97 |
| 2020-12-31 | $0.34B | $0.04B | 8.87 |
| 2020-09-30 | $0.22B | $0.13B | 1.72 |
| 2020-06-30 | $0.13B | $0.13B | 1.03 |
| 2020-03-31 | $0.15B | $0.13B | 1.16 |
| 2019-12-31 | $0.07B | $0.05B | 1.38 |
| 2019-09-30 | $0.06B | $0.05B | 1.22 |
| 2019-06-30 | $0.08B | $0.05B | 1.65 |
| 2019-03-31 | $0.09B | $0.05B | 2.06 |
| 2018-12-31 | $0.11B | $0.03B | 4.23 |
| 2018-09-30 | $0.12B | $0.02B | 5.74 |
| 2018-06-30 | $0.07B | $0.02B | 3.28 |
| 2018-03-31 | $0.09B | $0.03B | 3.60 |
| 2017-12-31 | $0.08B | $0.03B | 2.74 |
| 2017-09-30 | $0.10B | $0.03B | 3.15 |
| 2017-06-30 | $0.12B | $0.04B | 3.24 |
| 2017-03-31 | $0.07B | $0.04B | 2.06 |
| 2016-12-31 | $0.09B | $0.03B | 2.77 |
| 2016-09-30 | $0.11B | $0.03B | 3.30 |
| 2016-06-30 | $0.12B | $0.03B | 3.66 |
| 2016-03-31 | $0.11B | $0.03B | 3.34 |
| 2015-12-31 | $0.10B | $0.04B | 2.61 |
| 2015-09-30 | $0.08B | $0.04B | 1.93 |
| 2015-06-30 | $0.08B | $0.04B | 2.01 |
| 2015-03-31 | $0.09B | $0.04B | 2.24 |
| 2014-12-31 | $0.11B | $0.03B | 3.38 |
| 2014-09-30 | $0.10B | $0.03B | 3.53 |
| 2014-06-30 | $0.11B | $0.03B | 3.95 |
| 2014-03-31 | $0.12B | $0.02B | 5.50 |
| 2013-12-31 | $0.12B | $0.02B | 5.16 |
| 2013-09-30 | $0.13B | $0.02B | 5.87 |
| 2013-06-30 | $0.11B | $0.02B | 7.41 |
| 2013-03-31 | $0.12B | $0.01B | 8.53 |
| 2012-12-31 | $0.11B | $0.02B | 7.15 |
| 2012-09-30 | $0.12B | $0.01B | 8.96 |
| 2012-06-30 | $0.14B | $0.02B | 9.54 |
| 2012-03-31 | $0.17B | $0.02B | 8.33 |
| 2011-12-31 | $0.18B | $0.02B | 9.50 |
| 2011-09-30 | $0.20B | $0.02B | 9.47 |
| 2011-06-30 | $0.23B | $0.02B | 10.49 |
| 2011-03-31 | $0.25B | $0.02B | 10.39 |
| 2010-12-31 | $0.29B | $0.02B | 13.74 |
| 2010-09-30 | $0.00B | $0.02B | 0.00 |
| 2010-06-30 | $0.00B | 0.00 | |
| 2010-03-31 | $0.00B | 0.00 | |
| 2009-12-31 | $0.00B | 0.00 | |
| 2009-09-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.849B | $0.201B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.756B | 26.24 |
| Intuitive Surgical (ISRG) | United States | $136.392B | 85.13 |
| Edwards Lifesciences (EW) | United States | $54.342B | 35.97 |
| DexCom (DXCM) | United States | $52.484B | 90.16 |
| IQVIA Holdings (IQV) | United States | $42.513B | 25.21 |
| IDEXX Laboratories (IDXX) | United States | $41.344B | 49.43 |
| Alcon (ALC) | Switzerland | $40.079B | 29.56 |
| STERIS (STE) | Ireland | $20.158B | 23.86 |
| Waters (WAT) | United States | $19.102B | 27.46 |
| Hologic (HOLX) | United States | $18.152B | 20.03 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.645B | 0.00 |
| ShockWave Medical (SWAV) | United States | $12.255B | 84.68 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $10.792B | 13.33 |
| Teleflex (TFX) | United States | $10.100B | 15.86 |
| Sysmex ADR (SSMXY) | Japan | $10.076B | 31.60 |
| Penumbra (PEN) | United States | $8.416B | 104.04 |
| Masimo (MASI) | United States | $7.298B | 40.93 |
| Globus Medical (GMED) | United States | $6.995B | 22.18 |
| Glaukos (GKOS) | United States | $4.859B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.879B | 24.79 |
| TransMedics (TMDX) | United States | $3.004B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.859B | 18.86 |
| Elekta AB (EKTAY) | Sweden | $2.693B | 18.47 |
| PROCEPT BioRobotics (PRCT) | United States | $2.584B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.578B | 10.58 |
| Inari Medical (NARI) | United States | $2.364B | 407.80 |
| Nihon Kohden (NHNKY) | Japan | $2.359B | 19.95 |
| Tandem Diabetes Care (TNDM) | United States | $2.163B | 0.00 |
| RxSight (RXST) | United States | $2.037B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.835B | 0.00 |
| Veracyte (VCYT) | United States | $1.519B | 0.00 |
| OPKO Health (OPK) | United States | $0.857B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.855B | 15.82 |
| Paragon 28 (FNA) | United States | $0.850B | 0.00 |
| Artivion (AORT) | United States | $0.843B | 97.43 |
| OrthoPediatrics (KIDS) | United States | $0.740B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.734B | 0.00 |
| Silk Road Medical (SILK) | United States | $0.713B | 0.00 |
| SiBone (SIBN) | United States | $0.615B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.566B | 19.23 |
| IRadimed (IRMD) | United States | $0.523B | 30.36 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.498B | 0.00 |
| Nevro (NVRO) | United States | $0.482B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.399B | 0.00 |
| CVRx (CVRX) | United States | $0.372B | 0.00 |
| NeuroPace (NPCE) | United States | $0.355B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.351B | 11.82 |
| AxoGen (AXGN) | United States | $0.315B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.288B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.281B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.255B | 0.00 |
| Accuray (ARAY) | United States | $0.226B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.208B | 0.00 |
| 908 Devices (MASS) | United States | $0.200B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.196B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.194B | 10.47 |
| Inogen (INGN) | United States | $0.172B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.157B | 0.00 |
| Neuronetics (STIM) | United States | $0.129B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.122B | 0.00 |
| Yubo Biotech (YBGJ) | China | $0.112B | 0.00 |
| Envoy Medical (COCH) | United States | $0.099B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.098B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.095B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.090B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.056B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.055B | 112.67 |
| Vicarious Surgical (RBOT) | United States | $0.055B | 0.00 |
| InspireMD (NSPR) | Israel | $0.054B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.054B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.046B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.043B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.040B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.039B | 0.00 |
| LENSAR (LNSR) | United States | $0.037B | 0.00 |
| DarioHealth (DRIO) | United States | $0.036B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.026B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.024B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.012B | 0.00 |
| Avinger (AVGR) | United States | $0.007B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.005B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |